Patent classifications
C12N15/8243
Tobacco arsenic transport gene NtNIP7-1 and cloning method and applications thereof
A tobacco arsenic transport gene NtNIP7-1 and a cloning method and application thereof are disclosed. A nucleotide sequence of the tobacco arsenic transport gene NtNIP7-1 is shown as SEQ ID: No. 1, and an encoded amino acid sequence thereof is shown as SEQ ID: No. 2. The cloning method of the tobacco arsenic transport gene NtNIP7-1 includes (S1) extracting RNA in tobacco, performing reverse transcription, and obtaining a first-strand cDNA; and (S2) taking the first-strand cDNA obtained by the reverse transcription as a template, synthesizing a specific primer according to sequences of the NtNIP7-1 gene, performing PCR amplification, recovering and purifying a product of the PCR amplification, and sequencing. In the present invention, inhibition of the expression of the tobacco endogenous gene NtNIP7-1 in tobacco plants is able to significantly reduce the arsenic content of tobacco leaves, and has broad application prospects in the field of low arsenic content breeding.
Method for differentiating cannabis plant cultivars based on cannabinoid synthase paralogs
Compositions and methods for providing desired cannabinoid content in cannabis plants. More particularly, the invention relates to compositions and methods for using cannabinoid synthase paralogs as guidance for breeding cannabis plants with a desired cannabinoid content, including but not limited to cultivars, varieties, lines and methods of breeding the same for commercial use.
Tobacco Having Altered Leaf Properties and Methods of Making and Using
This disclosure provides tobacco plants having a mutation in PR50 and transgenic tobacco plants containing a PR50 RNAi, and methods of making and using such plants.
PLANT BODY OF GENUS NICOTIANA WITH LOW ALKALOID CONTENT AND PRODUCTION METHOD THEREOF
An embodiment of the present invention provides a tobacco plant having a low alkaloid content. In the tobacco plant, a function of a gene encoding aspartate oxidase AO2 is suppressed.
CANNABIS TERPENE SYNTHASE PROMOTERS FOR THE MANIPULATION OF TERPENE BIOSYNTHESIS IN TRICHOMES
The present technology provides terpene synthase (TPS) promoters and TPS promoter consensus sequences from Cannabis, nucleotide sequences of the TPS promoters and consensus sequences, and uses of the promoters and consensus sequences for modulating the production of terpenes and other compounds in organisms The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the TPS promoters and consensus sequences. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the TPS promoters and consensus sequences.
PROTEIN COMPOSITION WITH ISOPRENE POLYMERIZATION ACTIVITY AND APPLICATION THEREOF
The present disclosure provides a means for efficiently producing natural rubber and stably providing the same, and is aimed at stably providing a rubber resource. The present disclosure may provide a protein composition that exhibits an isoprene polymerization activity and comprises a protein(s) (B) exhibiting the same activity as CPTL and either one of proteins (A-1) exhibiting the same activity as CPT6 or (A-2) exhibiting the same activity as CPT7, as well as a lipid membrane structure comprising the composition, a method for producing the same, a cell expressing a protein constituting the composition, a method for producing the same, and a method for producing an isoprene polymer compound using any of the above.
Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction and Alzheimer's disease
Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction, and Alzheimer's disease by administering to an individual in need thereof a pharmaceutical composition including a compound having the structure: ##STR00001##
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
Grain with increased nicotianamine
A grain crop may have an increased amount of nicotianamine (NA). The increased NA may correlate with an increased bioavailability of iron in the grain and any product, such as ground flour, resulting from processing of the grain. The increase of NA may be achieved through the expression of the OsNAS2 gene. Further, a grain flour produced from a transformed grain plant may have an increased amount of NA, and thus an increased amount of bio-available iron, as compared to a grain flour produced from a non-transformed grain plant of the same species. The grain flour produced from the transformed grain plant (“biofortified flour”) may be used in food production for feed to animals or humans. Such a feed including the biofortified flour may improve the gut health and/or the feed efficiency of the eater as compared to the gut health for an eater of non-biofortified flour.
Mutant of lycopene epsilon cyclase (LCYE) gene crucial in wheat carotenoid synthesis pathway and use thereof
The present disclosure discloses a mutant of a lycopene epsilon cyclase (Lcye) gene crucial in a wheat carotenoid synthesis pathway and use thereof. The present disclosure provides the following proteins: (1) a protein obtained by substituting serine at position 253 of an Lcye-D1 protein with phenylalanine; (2) a derived protein that is obtained by subjecting the protein in (1) to substitution and/or deletion and/or addition of one or more amino acid residues and has the same ability as the protein in (1); (3) a protein that has a homology of more than 99%, more than 95%, more than 90%, more than 85%, or more than 80% with the amino acid sequence defined in any one of (1) and (2) and has the same function as the amino acid sequence; and (4) a fusion protein obtained by attaching a tag to N-terminus and/or C-terminus of the protein in any one of (1) to (3). The present disclosure not only verifies the function of an Lcye gene, but also provides a theoretical basis and a germplasm resource for improving the color character of flour and products thereof.
METHOD
The present invention provides a method for modulating (e.g. decreasing) the nicotine content of a plant (e.g. a tobacco plant) or part thereof, or tobacco plant cell, the method comprising modifying said plant or cell providing at least one mutation in a Nic3 locus. The present invention provides a method for modulating (e.g. decreasing) the nicotine content of a plant (e.g. a tobacco plant) or part thereof, or tobacco plant cell, the method comprising modifying said plant or cell to modulate the expression or activity of at least one Nic3 gene. The present invention also provides for the use of the Nic3 locus for modulating the alkaloid content of a plant, as well as tobacco cells, plants, plant propagation materials, harvested leaves, processed tobaccos, or delivery systems obtainable in accordance with the invention.